In this episode we look at how T-cell based therapies are being developed for use in solid cancers. Claire Roddie is a UCLH consultant specialising in CAR T-cell treatment and discusses tumour infiltrating lymphocytes, neo-antigen receptors, checkpoint inhibitors and the barriers that need to be overcome to develop effective immunotherapy treatments for solid cancers.
